Improved therapy for atopic eczema. New immunomodulators clear the rash with few side effects.
Smith
Jennifer S
JS
Northeastern Ohio Universities College of Medicine, Rootstown, Ohio, USA.
Brodell
Robert T
RT
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D003876:Dermatitis, Atopic / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D007223:Infant; D016559:Tacrolimus / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome
D000276:Adjuvants, Immunologic; D007166:Immunosuppressive Agents; D016559:Tacrolimus